ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update

Core Insights - ONWARD Medical N.V. is set to report its Full-Year 2025 Financial Results and provide a business update on March 31, 2026 [1][2] Company Overview - ONWARD Medical is a leading neurotechnology company focused on therapies to restore movement, function, and independence for individuals with spinal cord injuries and other movement disabilities [3] - The company has developed proprietary ARC Therapy, which has received 10 Breakthrough Device Designations from the FDA [3] - The ARC-EX System is commercially available in the US and Europe, while the investigational ARC-IM system is being developed to address unmet needs such as blood pressure instability after spinal cord injury [3] - The company is headquartered in the Netherlands, with additional facilities in Switzerland and the US [4] Future Developments - The ARC-IM system is designed to be paired with brain-computer interfaces (BCI) and artificial intelligence (AI) to facilitate thought-driven movement [3]